Endocrine System Channel
Topics
Medications
Quicklinks
Related Channels

Drug Interactions With Insulin Glulisine

Alcohol, ACE inhibitors, and certain antibiotics are among the substances that can cause negative interactions with insulin glulisine. Drug interactions such as these can cause dangerously low blood sugar levels. To avoid this complication, your healthcare provider may recommend another medication or advise you to closely monitor your blood sugar levels for a while to see if you need to adjust your insulin glulisine dosage.

Drug Interactions With Insulin Glulisine: An Overview

Insulin glulisine (Apidra®) can potentially interact with numerous other medicines, too many to list here. Some interactions (which are not discussed in this article) may increase blood sugar levels, which is not healthy, but is usually not dangerous in the short term. Other drug interactions with insulin glulisine can result in dangerously low blood sugar levels (hypoglycemia). Some of the medicines that may cause dangerously low blood sugar when combined with insulin glulisine include:
 
  • Alcoholic beverages
  • Angiotensin-converting enzyme inhibitors (ACE inhibitors), such as:
 
 
 
 
 
 
  • Monoamine oxidase inhibitors (MAOIs), such as:
 
 
 
    • Aspirin (Ecotrin®, Bayer®, Anacin®)
    • Choline magnesium trisalicylate (Trilisate®)
    • Diflunisal (Dolobid®)
    • Salsalate (Salflex®, Disalcid®, Amigesic®)
 
  • Sulfonamide antibiotics ("sulfa drugs"), such as:
 
    • Sulfadiazine
    • Sulfadoxine (Fansidar®)
    • Sulfamethoxazole (Bactrim®, Septra®)
    • Sulfisoxazole (Gantrisin®).
 
7 Signs of High Blood Sugar

Insulin Glulisine Drug Information

Referring Pages:
Terms of Use
Advertise with Us
Contact Us
About eMedTV
Privacy Policy
Copyright © 2006-2017 Clinaero, Inc.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.